REGEN Biotech is a research-driven biotechnology company dedicated to the commercialization of innovative biomedical technologies developed in collaboration with leading Korean research institutions, including the Korea Institute of Science and Technology (KIST) Medical Science Center, the Korea Advanced Institute of Science and Technology (KAIST) Department of Biological Sciences, and other prominent academic and scientific organizations. The company focuses on translating cutting-edge research into clinically relevant and commercially successful healthcare solutions.

REGEN Biotech has established world-class expertise in the development and fabrication of therapeutic tissue-regeneration scaffolds utilizing biocompatible polymers and regenerative peptides. Its proprietary technologies have led to the successful commercialization of innovative regenerative medicine products, including scaffold-based solutions that have received approval from the Korea Food and Drug Administration (KFDA). Building on its proven track record in tissue engineering and regenerative medicine, REGEN Biotech continues to advance research and development in next-generation biomedical applications.